Angelos M Stergiou

Title: Angelos M Stergiou: Innovator in Mucositis Treatment

Introduction

Angelos M Stergiou is a notable inventor based in Athens, Greece. He has made significant contributions to the field of medical treatments, particularly in the area of mucositis. With a total of 2 patents to his name, Stergiou's work focuses on innovative formulations and devices aimed at improving patient care.

Latest Patents

Stergiou's latest patents include formulations, devices, and methods for treating and preventing mucositis, specifically chronic rhinosinusitis (CRS). These inventions are designed to provide non-irritative treatment options. The compositions involve sodium phosphate buffer and calcium carbonate, which are essential for effective mucoadministration. The methods outlined in his patents emphasize the importance of delivering these compositions to patients in need, thereby enhancing their quality of life.

Career Highlights

Throughout his career, Stergiou has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Accentia Biopharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

One of Stergiou's notable collaborators is Francis E O'Donnell, Jr. Their partnership has likely fostered the development of new ideas and solutions in the field of mucositis treatment.

Conclusion

Angelos M Stergiou's contributions to the treatment of mucositis through his innovative patents highlight his dedication to improving patient outcomes. His work continues to influence the medical field, showcasing the importance of research and development in healthcare.